Ginkgo Bioworks Holdings (DNA) Gross Profit (2020 - 2026)

Ginkgo Bioworks Holdings' Gross Profit history runs 7 years deep, the most recent figure standing at $16.4 million for Q1 2026.

• Quarterly Gross Profit fell 52.03% year-over-year to $16.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $105.7 million (down 51.33% YoY) and the FY2025 annual result came in at $141.3 million, down 36.1% from the prior year.
• Gross Profit was $16.4 million for Q1 2026 at Ginkgo Bioworks Holdings, up from $14.5 million in the prior quarter.
• Across five years, Gross Profit topped out at $251.6 million in Q4 2022 and bottomed at $14.5 million in Q4 2025.
• A 5-year average of $81.4 million and a median of $48.5 million in 2023 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2022 — Gross Profit jumped 428.52% — and 2024, when it plunged 83.33%.
• Ginkgo Bioworks Holdings' Gross Profit stood at $251.6 million in 2022, then declined by 0.43% to $250.6 million in 2023, then plunged by 83.33% to $41.8 million in 2024, then plunged by 65.34% to $14.5 million in 2025, then increased by 13.1% to $16.4 million in 2026.
• Business Quant data shows DNA's Gross Profit at $16.4 million in Q1 2026, $14.5 million in Q4 2025, and $30.7 million in Q3 2025.